Key dates
Raised 2,5M$ investment
November 2020 – AbolerIS Pharma raises 2,5M$ in Seed Financing from Newton Biocapital and Turenne Santé/Sham Innovation Santé.
AbolerIS Pharma foundation
Press releases
AbolerIS Pharma is one of the laureates of the 23rd edition of the i-Lab
innovation contest 2021
AbolerIS Pharma Strengthens Management Team to Support Next Phases of Growth.
AbolerIS Pharma’s co-founder Dr. Ignacio Anegon is promoted by the INSERM to the highest position in the French research system
AbolerIS Pharma’s co-founder Dr. Carole Guillonneau receives Albert Sezary Prize from the National Academy of Medicine.
AbolerIS Pharma signed an exclusive world-wide license with Ouest Valorisation to develop new first-in-class anti-CD45RC antibodies.
AbolerIS Pharma Raises €2.5M in Seed Financing from Newton Biocapital and Turenne Santé/Sham Innovation Santé.
Events
New dates to come soon.